A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2009
10/01/2009	US20090246793 Cudr as biomarker for cancer progression and therapeutic response
10/01/2009	US20090246269 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease
10/01/2009	US20090246230 Compositions and methods for inducing tumor resistance
10/01/2009	US20090246229 Subunit vaccine of pasteurella multocida in veterinary uses
10/01/2009	US20090246228 Moraxella catarrhalis Proteins
10/01/2009	US20090246227 Methods of use for hsv-1 and hsv-2 vaccines
10/01/2009	US20090246226 Avian vaccines possessing a positive marker gene
10/01/2009	US20090246225 Methods of Producing Influenza Vaccine Compositions
10/01/2009	US20090246224 Vaccine
10/01/2009	US20090246223 Inactivated Chimeric Vaccines and Related Methods of Use
10/01/2009	US20090246222 Live Attenuated Bordetella Strains as a Single Dose Vaccine Against Whooping cough
10/01/2009	US20090246221 Immunomodulatory agents and methods of use
10/01/2009	US20090246220 Constructs for enhancing immune responses
10/01/2009	US20090246219 NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)
10/01/2009	US20090246218 S. aureus fibrinogen binding protein gene
10/01/2009	US20090246217 Novel Peptides for Treating and Preventing Immune-Related Disorders, Including Treating and Preventing Infection by Modulating Innate Immunity
10/01/2009	US20090246216 Novel attenuated poliovirus
10/01/2009	US20090246215 Amyloid beta1-6 antigen arrays
10/01/2009	US20090246214 Fusion proteins containing recombinant cytotoxic rnases
10/01/2009	US20090246213 Vaccine comprising a polynucleotide encoding an antigen recognized by a cd4+ helper t-cell and a polynucleotide encoding a tumor specific or associated antigen recognized by a cd8+ ctl
10/01/2009	US20090246212 Development of method for screening for drug capable of improving production of regulatory t cells and method for producing regulatory t cells using immunosuppressive macrolide antibiotic
10/01/2009	US20090246211 Molecular constructs suitable for targeted conjugates
10/01/2009	US20090246210 IL-1Beta Binding Antibodies and Binding Fragments thereof
10/01/2009	US20090246209 Gnrh analogues for treatment of urinary incontinence
10/01/2009	US20090246208 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
10/01/2009	US20090246207 Calf Biologic Anti-Scour Supplement (CBAS)
10/01/2009	US20090246206 Bispecific binding agents for modulating biological activity
10/01/2009	US20090246205 Inhibition of macrophage-stimulating protein receptor (ron)
10/01/2009	US20090246204 Use of a cd28 binding substance for making a pharmaceutical composition
10/01/2009	US20090246203 Method for immunoadsorption by means of autoanitgens
10/01/2009	US20090246202 Human Endokine Alpha and Methods of Use
10/01/2009	US20090246201 Substances
10/01/2009	US20090246200 Anthrax carbohydrates, synthesis and uses thereof
10/01/2009	US20090246199 Therapeutic methods for inhibiting tumor growth with dll4 antagonists
10/01/2009	US20090246198 Mapk/erk kinase inhibitors and methods of use thereof
10/01/2009	US20090246197 Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc)
10/01/2009	US20090246196 Combined targeted therapy for the treatment of proliferative disease
10/01/2009	US20090246195 Anti-cd19 antibody therapy for transplantation
10/01/2009	US20090246194 ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINS
10/01/2009	US20090246193 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
10/01/2009	US20090246192 1D05 PCSK9 antagonists
10/01/2009	US20090246191 Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof
10/01/2009	US20090246190 Monoclonal antibody that binds human vascular endothelial grwoth factor; can be used to treat edema and other unwanted cell proliferation
10/01/2009	US20090246189 Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons
10/01/2009	US20090246180 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/01/2009	US20090246173 Treatment with anti-vegf antibodies
10/01/2009	US20090246168 Antitumoral treatments
10/01/2009	US20090246142 Triggered Self-Assembly of Nanoparticles In Vivo
10/01/2009	US20090246132 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction
10/01/2009	US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
10/01/2009	US20090246129 Compositions and methods for the diagnosis and treatment of tumor
10/01/2009	CA2719786A1 Methods of treatment
10/01/2009	CA2719761A1 Glucagon receptor antagonists
10/01/2009	CA2719614A1 Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
10/01/2009	CA2719582A1 Neurodegenerative disorders
10/01/2009	CA2719553A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
10/01/2009	CA2719400A1 Anti-vegf antibody
10/01/2009	CA2719290A1 Use of benzophenone derivative or salt thereof and tnf.alpha. inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
10/01/2009	CA2719247A1 Ikki inhibitor therapies and screening methods, and related ikki diagnostics
10/01/2009	CA2719201A1 Neutralizing molecules to viral antigens
10/01/2009	CA2719041A1 Compositions, methods, and kits
10/01/2009	CA2718994A1 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies
10/01/2009	CA2718731A1 Recombinant rhinovirus vectors
10/01/2009	CA2717905A1 Methods and compositions for treating bone loss
10/01/2009	CA2716884A1 Use of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) in combination with cyclophosphamide, vincristine and doxorubicine for treating non-hodgkin's lymphomas
10/01/2009	CA2716882A1 Compositions and methods for inhibiting pdgfrbeta and vegf-a
10/01/2009	CA2712535A1 An anti-cancer cytotoxic monoclonal antibody
09/2009
09/30/2009	EP2105511A1 Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung
09/30/2009	EP2105504A2 Genes and proteins, and their use
09/30/2009	EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer
09/30/2009	EP2105501A1 Novel immunotherapy against neuronal and brain tumors
09/30/2009	EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein
09/30/2009	EP2105448A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
09/30/2009	EP2105129A2 Encapsulated Vaccines for the Oral Vaccination and Boostering of Fish and Other Animals
09/30/2009	EP2104732A1 Cancerous disease modifying antibodies
09/30/2009	EP2104513A2 Ovr110 antibody compositions and methods of use
09/30/2009	EP2104512A2 Streptococcus proteins, and their use in vaccination
09/30/2009	EP2104488A2 Gas-filled microvesicles with targeting ligand in respect of fc-region of an antibody or therapeutic agent
09/30/2009	EP1693378B1 Protein nmb1125 and use thereof in pharmaceutical formulations
09/30/2009	EP1465928B1 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies
09/30/2009	EP1407007B1 Attenuated circovirus
09/30/2009	EP1309627B1 Immunotherapy for chronic myelocytic leukemia with naked anti-nca-90 antibody
09/30/2009	EP1286689B1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
09/30/2009	EP1242122B1 Delivery of proteins across polar epithelial cell layers
09/30/2009	EP1240325B1 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
09/30/2009	EP1185655B1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
09/30/2009	EP0623168B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
09/30/2009	CN101547705A Compositions and methods for treating a neoplasm
09/30/2009	CN101544962A EV virus wide spectrum monoclonal antibody and its uses
09/30/2009	CN101544694A Anti-CD20 tetravalent antibody and preparation method and application thereof
09/30/2009	CN101544689A Leptospira vaccine candidate outer membrane protein
09/30/2009	CN101543627A Traditional Chinese medicine composition of composite immune globulin for treating respiratory diseases of poultry
09/30/2009	CN101543513A Method using coupling of probiotic bacteria and virus for producing medicine
09/30/2009	CN101543507A Immunostimulatory nucleic acids
09/30/2009	CN100545174C Compositions and methods for wt1 specific immunotherapy
09/29/2009	US7595383 Secreted proteins of Mycobacterium tuberculosis and their use as vaccines and diagnostic reagents
09/29/2009	US7595378 Can be produced by a transfectoma or in a non-human transgenic animal
09/29/2009	US7595298 Ala-Arg-Nal-Cys-Tyr-Arg-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg; viricide; low cytotoxicity
09/29/2009	US7595292 Conjugated biological molecules and their preparation
09/29/2009	US7595192 Obtained by inducing necrosis by temperature in tumor cells and lysing the necrotic tumor cells; vaccines against cancers, tumorous diseases, infections and/or autoimmune diseases

1 ... 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 ... 1823